221 related articles for article (PubMed ID: 31231909)
21. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
22. The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours.
Fröstad B; Tani E; Kogner P; Maeda S; Björk O; Skoog L
Eur J Cancer; 1998 Mar; 34(4):529-36. PubMed ID: 9713304
[TBL] [Abstract][Full Text] [Related]
23. Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group.
Joshi VV; Silverman JF; Altshuler G; Cantor AB; Larkin EW; Neill JS; Norris HT; Shuster JJ; Holbrook CT; Hayes FA
Hum Pathol; 1993 May; 24(5):493-504. PubMed ID: 8491489
[TBL] [Abstract][Full Text] [Related]
24. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy.
Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
Cancer Cytopathol; 2022 Feb; 130(2):128-135. PubMed ID: 34633743
[TBL] [Abstract][Full Text] [Related]
25. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
27. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Larkin EW; Neill JS; Shuster JJ; Holbrook CT; Hayes FA; Castleberry RP
Cancer; 1992 Apr; 69(8):2183-96. PubMed ID: 1544124
[TBL] [Abstract][Full Text] [Related]
28. Cytopathology of neuroblastoma, ganglioneuroblastoma and ganglioneuroma.
Mondal A
J Indian Med Assoc; 1995 Sep; 93(9):340-3. PubMed ID: 8648154
[TBL] [Abstract][Full Text] [Related]
29. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration cytology of ganglioneuroma.
Catalina-Fernández I; Sáenz-Santamaria J; López-Presa D
Acta Cytol; 2008; 52(3):380-1. PubMed ID: 18540312
[No Abstract] [Full Text] [Related]
32. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
Munchar MJ; Sharifah NA; Jamal R; Looi LM
Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
[TBL] [Abstract][Full Text] [Related]
33. Pathology of neuroblastic tumors.
Joshi VV; Silverman JF
Semin Diagn Pathol; 1994 May; 11(2):107-17. PubMed ID: 7809504
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
Hicks MJ; Mackay B
Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
[TBL] [Abstract][Full Text] [Related]
35. Tumors of the neuroblastoma group.
Shimada H
Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
[TBL] [Abstract][Full Text] [Related]
36. [Peripheral neuroblastic tumors in childhood].
Bernhardt M; Vokuhl C
Pathologie (Heidelb); 2023 Nov; 44(6):366-372. PubMed ID: 37819531
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Alexander N; Sullivan K; Shaikh F; Irwin MS
Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
[TBL] [Abstract][Full Text] [Related]
38. Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements.
Yu Y; Zhang M; Yao X; Guan X; Jia C; Chu P; Zhang R; Yang Y; Jin Y; Wang H; Ni X; He L; Guo Y
J Pathol Clin Res; 2023 Nov; 9(6):475-487. PubMed ID: 37608330
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma.
Gahr N; Darge K; Hahn G; Kreher BW; von Buiren M; Uhl M
Eur J Radiol; 2011 Sep; 79(3):443-6. PubMed ID: 20462716
[TBL] [Abstract][Full Text] [Related]
40. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]